Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Eva Karamitopoulou"'
Autor:
Eva Karamitopoulou, Aurélie Pahud de Mortanges, Aurel Perren, Beat Gloor, Andreas Andreou, Marianne Tinguely
Publikováno v:
Cancer Immunology Research. 9:1439-1450
Immunotherapy, including PD-1/PD-L1 agonists, has shown limited efficacy in pancreatic ductal adenocarcinoma (PDAC). We examined the PD-1/PD-L1 expression and immunoarchitectural features by automated morphometric analysis using multiplex immunofluor
Autor:
Eva Karamitopoulou, Hanna Seppänen, Giulia Zamboni, Marc Zins, Giulia Martina Cavestro, Thomas Brunner, Alberto Costa, Filippo de Braud, Danila Valenti, Franco Orsi, Francesco Sclafani, Sorin T. Barbu, Martina Torchio, Cindy Neuzillet, Marc Beishon, Ken Herrmann, Mirjam Crul, Pierluigi Bonomo, Philip Poortmans, S. Partelli, Piero Ferolla, Maria Die Trill, Graça Braz
Publikováno v:
Cancer treatment reviews
Partelli, S, Sclafani, F, Barbu, S T, Beishon, M, Bonomo, P, Braz, G, de Braud, F, Brunner, T, Cavestro, G M, Crul, M, Trill, M D, Ferollà, P, Herrmann, K, Karamitopoulou, E, Neuzillet, C, Orsi, F, Seppänen, H, Torchio, M, Valenti, D, Zamboni, G, Zins, M, Costa, A & Poortmans, P 2021, ' European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC) : Pancreatic Cancer ', Cancer Treatment Reviews, vol. 99, 102208, pp. 102208 . https://doi.org/10.1016/j.ctrv.2021.102208
Partelli, S, Sclafani, F, Barbu, S T, Beishon, M, Bonomo, P, Braz, G, de Braud, F, Brunner, T, Cavestro, G M, Crul, M, Trill, M D, Ferollà, P, Herrmann, K, Karamitopoulou, E, Neuzillet, C, Orsi, F, Seppänen, H, Torchio, M, Valenti, D, Zamboni, G, Zins, M, Costa, A & Poortmans, P 2021, ' European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC) : Pancreatic Cancer ', Cancer Treatment Reviews, vol. 99, 102208, pp. 102208 . https://doi.org/10.1016/j.ctrv.2021.102208
European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC) are written by experts representing all disciplines involved in cancer care in Europe. They give patients, health professionals, managers and policymakers a guide to
Autor:
Martin Wartenberg, Irene Esposito, Inti Zlobec, David F. Schaeffer, Stefano La Rosa, Philipp Lohneis, Eva Karamitopoulou, Christine Sempoux, Steve E. Kalloger, Irene Centeno, Andrea Cacciato Insilla
Publikováno v:
Virchows Archiv, vol. 478, no. 4, pp. 719-726
Karamitopoulou, Evanthia; Esposito, Irene; Zlobec, Inti; Insilla, Andrea Cacciato; Wartenberg, Martin; Schaeffer, David F; Kalloger, Steve; La Rosa, Stefano; Sempoux, Christine; Ramos Centeno, Irene; Lohneis, Philipp (2021). Reproducibility of tumor budding assessment in pancreatic cancer based on a multicenter interobserver study. Virchows Archiv, 478(4), pp. 719-726. Springer 10.1007/s00428-020-02987-2
Virchows Archiv
Karamitopoulou, Evanthia; Esposito, Irene; Zlobec, Inti; Insilla, Andrea Cacciato; Wartenberg, Martin; Schaeffer, David F; Kalloger, Steve; La Rosa, Stefano; Sempoux, Christine; Ramos Centeno, Irene; Lohneis, Philipp (2021). Reproducibility of tumor budding assessment in pancreatic cancer based on a multicenter interobserver study. Virchows Archiv, 478(4), pp. 719-726. Springer 10.1007/s00428-020-02987-2
Virchows Archiv
Tumor budding has been reported to be an independent prognostic factor in pancreatic ductal adenocarcinoma (PDAC). Its use in daily diagnostics would improve the prognostic stratification of patients. We performed a multicenter interobserver study to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c6bca94aafcdd50def509494ea2ed6a
https://serval.unil.ch/resource/serval:BIB_A067A873B573.P001/REF.pdf
https://serval.unil.ch/resource/serval:BIB_A067A873B573.P001/REF.pdf
Pancreatic Cancers with High Grade Tumor Budding Exhibit Hallmarks of Diminished Anti-Tumor Immunity
Publikováno v:
Cancers
Cancers, Vol 13, Iss 1090, p 1090 (2021)
Volume 13
Issue 5
Sadozai, Hassan; Acharjee, Animesh; Gruber, Thomas; Gloor, Beat; Karamitopoulou, Eva (2021). Pancreatic Cancers with High Grade Tumor Budding Exhibit Hallmarks of Diminished Anti-Tumor Immunity. Cancers, 13(5) MDPI AG 10.3390/cancers13051090
Cancers, Vol 13, Iss 1090, p 1090 (2021)
Volume 13
Issue 5
Sadozai, Hassan; Acharjee, Animesh; Gruber, Thomas; Gloor, Beat; Karamitopoulou, Eva (2021). Pancreatic Cancers with High Grade Tumor Budding Exhibit Hallmarks of Diminished Anti-Tumor Immunity. Cancers, 13(5) MDPI AG 10.3390/cancers13051090
Simple Summary Pancreatic cancer, in its most common manifestation pancreatic ductal adenocarcinoma (PDAC), is a uniquely lethal disease with very limited treatment options and few prognostic biomarkers. Tumor budding is a proven independent, adverse
Autor:
Eva Karamitopoulou
Publikováno v:
British Journal of Cancer
Pancreatic cancer is a lethal disease, with fewer than 7% of patients surviving beyond 5 years following diagnosis. Immune responses are known to influence tumour progression. The dynamic interaction between cancer cells and immune cells in the tumou
Autor:
Eva Karamitopoulou
Publikováno v:
Cancers
Cancers, Vol 12, Iss 3076, p 3076 (2020)
Cancers, Vol 12, Iss 3076, p 3076 (2020)
Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis along with rising incidence rates and will be responsible for many cancer deaths in the future [...]
Autor:
Bruce Beutler, Viktor H. Koelzer, Lukas F. Mager, Vera Genitsch, Lester Thoo, Cedric Simillion, Rémy Bruggmann, Irene Keller, Martin Faderl, Ivonne Koeck, Inti Zlobec, Eva Karamitopoulou, Irina Tcymbarevich, Pascal Juillerat, Simona P. Pfister, Kathy D. McCoy, Xiaohong Li, Siegfried Hapfelmeier, Ruth Lyck, Andrew J. Macpherson, Christoph Müller, Philippe Krebs, Regula Stuber, Maya Langenegger, Yu Xia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f9c0aee87721577548b5992f90711a9
https://doi.org/10.7554/elife.28366.045
https://doi.org/10.7554/elife.28366.045
Publikováno v:
British Journal of Cancer
In 2011, the Tumour Node Metastasis (TNM) staging system still remains the gold standard for stratifying colorectal cancer (CRC) patients into prognostic subgroups, and is considered a solid basis for treatment management. Nevertheless, there is stil
Autor:
Salvatore Piscuoglio, Luigi Terracciano, Romina Sepe, Francesco Esposito, Pierlorenzo Pallante, Arthur Zimmermann, Alfredo Fusco, Eva Karamitopoulou, Ioannis Diamantis, Inti Zlobec
Publikováno v:
Histopathology. 60:397-404
Pancreatic ductal adenocarcinoma follows a multistep model of progression through precursor lesions called pancreatic intraepithelial neoplasia (PanIN). The high mobility group A1 (HMGA1) and high mobility group A2 (HMGA2) proteins are architectural
Autor:
Alessandro Lugli, Beat Gloor, Silvia Cibin, Martin Wartenberg, Inti Zlobec, Mathias Worni, Eva Karamitopoulou-Diamantis
Publikováno v:
Pancreatology. 17:S71-S72